PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH CANCER
Cancer is one of the most significant risk factors for venous thromboembolic events (VTEE). The article discusses the contemporary landscape of drug thromboprophylaxis in various groups of patients with cancer.
Main Author: | Ju. A. Fedotkina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«REMEDIUM GROUP» Ltd.
2019-06-01
|
Series: | Атеротромбоз |
Subjects: | |
Online Access: | https://www.aterotromboz.ru/jour/article/view/179 |
Similar Items
-
Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
by: O. V. Shatalova
Published: (2015-12-01) -
Risk of venous thromboembolism in patients with pancreatic cancer
by: O. I. Kit, et al.
Published: (2022-06-01) -
CLINICAL DISCUSSION OF A PATIENT WITH RECURRENT VENOUS THROMBOEMBOLIC COMPLICATIONS
by: A. L. KOMAROV
Published: (2017-12-01) -
Risk of postoperative venous thromboembolic complication development in elderly patients
by: N. M. Krasnova, et al.
Published: (2018-03-01) -
Multimodal prevention of venous thromboembolic complications after total hip and knee joint endoprosthesis
by: Y. L. Shevchenko, et al.
Published: (2014-12-01)